Adaptive Biotechnologies ADPT
NASDAQ ADPT
$28.60 +0.93 (+3.36%)
As of: Sep 17, 2026 · 3:59 PM EDT

Adaptive Biotechnologies (ADPT) Revenue Growth (5y) (2023 - 2026)

Analysis

Adaptive Biotechnologies (ADPT) Revenue Growth (5y) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Natera 49.39 Bn 48.29 Bn 486.15 Mn
2 Quest Diagnostics 27.49 Bn 26.86 Bn 1.03 Bn
3 Labcorp Holdings 26.51 Bn 26.37 Bn 1.11 Bn
4 Guardant Health 23.17 Bn 22.12 Bn 219.03 Mn
5 Tempus AI 12.59 Bn 11.77 Bn 274.25 Mn
6 Caris Life Sciences 8.01 Bn 7.22 Bn 182.38 Mn
7 Sotera Health 5.53 Bn 5.17 Bn 177.96 Mn
8 BillionToOne 4.80 Bn 4.25 Bn 77.11 Mn
9 Adaptive Biotechnologies 4.40 Bn 4.05 Bn 51.39 Mn
10 iRhythm Holdings 3.68 Bn 3.08 Bn 163.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.19%
Mar 31, 2026 13.02%
Dec 31, 2025 18.88%
Sep 30, 2025 29.01%
Jun 30, 2025 22.91%
Mar 31, 2025 20.19%
Dec 31, 2024 14.41%
Sep 30, 2024 12.25%
Jun 30, 2024 14.30%
Mar 31, 2024 27.02%
Dec 31, 2023 21.64%
Sep 30, 2023 17.15%
Jun 30, 2023 33.43%